FIELD: chemistry.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents a method of treating chronic kidney disease-mineral and bone disorder (CKD-MBD) in a patient receiving hemodialysis, wherein said method involves administering to patient a composition containing a compound, including Ac-c(C)arrrar-NH2 (SEQ ID NO: 3), and a pharmaceutically acceptable excipient, where composition is administered as intravenous injection during a period beginning approximately 15 minutes before completion of haemodialysis and ending approximately 3 hours after hemodialysis, and where said administering allows to efficiently maintain post-hemodialysis serum phosphorus level below serum phosphorus level prior to hemodialysis during a period, of at least approximately 6 hours after dialysis.
EFFECT: invention allows to mitigate post-dialysis rebound of serum phosphorus level.
7 cl, 3 dwg, 4 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENTS FOR REDUCTION OF PARATHYROID HORMONE LEVELS | 2010 |
|
RU2557654C2 |
| GLUCAGON ANALOGUES, POSSESSING HIGHER SOLUBILITY AND STABILITY IN BUFFERS WITH PHYSIOLOGICAL Ph VALUES | 2009 |
|
RU2560254C2 |
| AMIDE-BASED PRODRUGS OF GLUCAGON SUPERFAMILY PEPTIDES | 2009 |
|
RU2550696C2 |
| PHARMACEUTICAL STRUCTURES WITH INCREASED ALBUMIN BINDING AFFINITY | 2018 |
|
RU2753880C1 |
| ALPHA- AND GAMMA-MSH ANALOGUES | 2013 |
|
RU2668791C2 |
| PEPTIDES AND THEIR DERIVATIVES WHICH INTERACT WITH NICOTINIC ACETYLCHOLINE RECEPTOR AND SUITABLE FOR USE IN COSMETOLOGY AGAINST MIMIC AND AGE-RELATED WRINKLES | 2013 |
|
RU2524428C1 |
| LINKER LINKS AND MOLECULAR STRUCTURES CONTAINING THEM | 2018 |
|
RU2752671C2 |
| GLUCAGON ANALOGUES, HAVING HIGH SOLUBILITY IN PHYSIOLOGICAL pH BUFFERS | 2008 |
|
RU2477286C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| MODULATION OF COMPLEMENT ACTIVITY | 2015 |
|
RU2670988C2 |
